SAN DIEGO (AP) - Cancer patients increasingly are having their care guided by molecular tumor boards, a new version of the hospital panels that traditionally decided whether surgery, radiation or chemotherapy would be best.
These experts study a patient's cancer genes and match treatments to mutations that seem to drive the disease.
It's the kind of care that many experts say we should aim for - precision medicine, the right drug for the right person at the right time, guided by genes.
There are many success stories, but questions remain about whether it will improve survival, save money and improve care, and which patients should get which kind of genetic testing. Studies are underway now to try to sort that out.
(Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)